TrumpXi Summit Yields Soybean and Rare Earths Deals China Signals Tariff Reduction Paul McCartneys Final Appearance Highlights CBSs Financial Decision to End Colberts Late Show Enbridge Receives Higher Price Target as Cash Flow Outlook Remains Strong Indian Equity Markets Wobble as Sensex Nifty Fluctuate Hind Zinc SBI Force Motors Among Most Active Professional Title Gen Z Faces Diminishing Returns on Higher Education Amid Broader Economic Instability Bessent Predicts Substantial Disinflation as Fed Transition Under Warsh Begins Safehold Inc SAFE Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction ASAN Q1 2026 Earnings EPS Beats Estimates by 116 Stock Declines 26 BIOA Q1 2026 Earnings NarrowerThanExpected Loss Lifts Shares SITE Centers Corp SITC Q3 2025 Earnings Surprise EPS Beat Masks Lingering Headwinds MetLife Q1 2026 Earnings Strong EPS Beat Highlights Resilient Underwriting BBAR Q4 2025 Earnings Earnings Beat Estimates Despite Stock Decline Redhill Biopharma RDHL Holds Steady at 101 as Key Levels Define Trading Range ING Group ING Slips Slightly Amid Mixed Sector Sentiment Key Levels in Focus Kingsoft Cloud KC Inches Higher as Cloud Sector Momentum Builds Aptorum Group Limited APM Rises 296 as Stock Approaches Key Resistance Level Coeptis Therapeutics COEP Holds Steady at 164 as Key Levels Define Trading Range AtHome Pediatric Care Devices Could Address Access Gap for Millions of Children DTG Q1 2026 Earnings DTE Energy EPS Misses Estimates Revenue Not Disclosed Bond Price Slightly Down Middlesex Water MSEX Holds Steady Near Key Support as Trading Range Persists Inventiva SA IVA Slides 269 as Biotech Sentiment Sours Corcept Therapeutics CORT Edges Higher Amid Steady Support Levels Centurion Acquisition Corp Warrant ALFUW Holds Steady at 014 as Support and Resistance Levels Tighten Universe Pharmaceuticals UPC Surges 8 Key Support and Resistance Levels to Watch Core AI Holdings Inc CHAI Slight Pullback as Stock Holds Above Key Support Sprinklr Inc CXM Gains 256 as Stock Tests Key Resistance Level BioCryst Pharmaceuticals BCRX Surges 626 as Momentum Builds Above Key Support